MGTX MeiraGTx Holdings plc

MeiraGTx Announces Nine-Month Data from Phase 1/2 Trial of AAV-RPGR Demonstrating Significant and Sustained Vision Improvement in X-Linked Retinitis Pigmentosa (XLRP)

MeiraGTx Announces Nine-Month Data from Phase 1/2 Trial of AAV-RPGR Demonstrating Significant and Sustained Vision Improvement in X-Linked Retinitis Pigmentosa (XLRP)
EN
03/10/2020

Underlying

MGTXMeiraGTx Holdings plc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MeiraGTx Holdings plc

 PRESS RELEASE
Free
MGTX MeiraGTx Holdin...

MeiraGTx Announces the Presentation of Four Posters at the American So...

MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx’s Technology Platforms for Gene and Cell Therapy LONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced the Company will exhibit four poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting, which is being held from May 13-17, 2...

May 13, 2025 1 EN
 PRESS RELEASE
Free
MGTX MeiraGTx Holdin...

MeiraGTx Reports First Quarter 2025 Financial and Operational Results

MeiraGTx Reports First Quarter 2025 Financial and Operational Results -  Announced strategic collaboration with Hologen AI, including a $200 million cash upfront payment to MeiraGTx and the formation of a joint venture, Hologen Neuro AI Ltd, with a further $230 million in capital committed to initially focus on expediting Phase 3 clinical development of AAV-GAD for Parkinson’s disease -  U.S. Food and Drug Administration (FDA) Granted Regenerative Medicine Advanced Therapy (RMAT) designation for AAV-GAD for the treatment of Parkinson’s disease -  Gained alignme...

May 13, 2025 1 EN
 PRESS RELEASE
Free
MGTX MeiraGTx Holdin...

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Des...

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease -  This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time treatment for Parkinson’s disease -  RMAT designation includes the benefits of the Fast Track and Breakthrough Therapy designations, allows frequent regulatory interactions with the FDA, and potential routes to accelerated approval and Priority Review LONDON and NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (N...

May 9, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 42.68
ZBH ZIMMER BIOMET H...
ATNI ATN Internation... ... (+38)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ZBH ZIMMER BIOMET HOLDINGS INC.
ATNI ATN INTERNATIONAL INC.
VZ VERIZON COMMUNICATIONS INC.
SYNL SYNALLOY CORP.
SCCO SOUTHERN COPPER CORPORATION
RGR STURM RUGER & COMPANY INC.
MRCY MERCURY SYSTEMS INC.
MKTX MARKETAXESS HOLDINGS INC.
KR KROGER CO.
FCX FREEPORT-MCMORAN INC.
EIG EMPLOYERS HOLDINGS INC.
DG DOLLAR GENERAL CORPORATION
CBOE CBOE GLOBAL MARKETS INC
ALL ALLSTATE CORPORATION
R1D AERCAP HOLDINGS NV
FNF FIDELITY NATIONAL FINANCIAL INC. - FNF GROUP
CNR. CANADIAN NATIONAL RAILWAY COMPANY
DGICA DONEGAL GROUP INC. CL A
LFVN LIFEVANTAGE
BRK.B BERKSHIRE HATHAWAY INC. CLASS B
HRTG HERITAGE INSURANCE HOLDINGS INC.
THG HANOVER INSURANCE GROUP INC.
FTG111 FLATEXDEGIRO AG
PAGS PAGSEGURO DIGITAL LTD
MGTX MEIRAGTX HOLDINGS PLC
OPRX OPTIMIZERX CORP
GRPN GROUPON INC.
RKT ROCKET COMPANIES
AVAH AVEANNA HEALTHCARE HLDGS INC
RGC REGENCELL BIOSCIENCE HLDGS LTD
QBTS D-WAVE QUANTUM INC.
ANG ANGLOGOLD ASHANTI LIMITED
METC RAMACO RESOURCES INC.
NXT NEXT GEOSOLUTIONS EUROPE S.P.A.
BNTC BENITEC BIOPHARMA INC
SARO STANDARDAERO INC.
ZBIO PROSHARES ULTRAPRO SHORT NASDAQ BIOTECHNOLOGY
USAU US GOLD CORP
03/14/25 March 14, 2025 1 EN
 PRESS RELEASE
Free
MGTX MeiraGTx Holdin...

MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Opera...

MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates -  Today announced strategic collaboration with Hologen AI, including a $200 million upfront payment to MeiraGTx and the formation of a joint venture, Hologen Neuro AI Ltd, with a further $230 million in capital committed to initially focus on expediting Phase 3 clinical development of AAV-GAD for Parkinson’s disease -  MeiraGTx and Hologen have created the first neuro-AI clinical drug development company to transform the discovery and development of therapies targeting CNS circ...

March 13, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch